Publish: Wednesday July 28, 2021 | 5:29 pm  |  অনলাইন সংস্করণ

 dhepa 

The German pharmaceutical group behind one of the most successful COVID-19 vaccines wants to use the same technology to develop a malaria vaccine.

BioNTech, who developed the first coronavirus jab with US company Pfizer, is aiming to begin clinical trials for a “safe and highly effective malaria vaccine” by the end of next year.

Array
We use all content from others website just for demo purpose. We suggest to remove all content after building your demo website. And Dont copy our content without our permission.
আমাদের ইউটিউব চ্যানেলে সাবস্ক্রাইব করুন

আর্কাইভ

June 2026
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930